References
- Julius S., Schork M. A. Borderline hypertension—a critical review. J Chronic Dis. 1971; 23: 723–754
- Neaton J. D., Kuller L., Stamler J., Wentworth D. N. Impact of systolic and diastolic blood pressure on cardiovascular mortality. Hypertension: Pathophysiology Diagnosis, and Management, J. H. Laragh, B. M. Brenner. Raven Press, Ltd, New York 1995; 127–144
- Julius S., Jamerson K., Mejia A., Krause L., Schork N., Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA. 1990; 264: 354–358
- Lund-Johansen P., Omvik P. Hemodynamic patterns of untreated hypertensive disease. Hypertension: Pathophysiology, Diagnosis, and Management, J. H. Laragh, B. M. Brenner. Raven Press, Ltd., New York 1990; 305–327
- Ellis C. N., Julius S. Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J. 1973; 35: 450–455
- Esler M., Julius S., Zweifler A., et al. Mild high-renin essential hypertension: Neurogenic human hypertension?. N Engl J Med 1977; 296: 405–411
- Kjeldsen S. E., Gjesdal K., Eide I., et al. Increased beta-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline platelet function and blood lipids. Acta Med Scand. 1983; 213: 369–373
- Julius S., Esler M. Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol. 1975; 36: 685–696
- Julius S., Pascual A. V., London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971; 44: 413–418
- Julius S., Krause L., Schork N., et al. Hyperkinetic borderline hypertension in Tecumseh Michigan. J Hypertens 1991; 9: 77–84
- Julius S., Schork N., Schork A. Sympathetic hyperactivity in early stages of hypertension: The Ann Arbor data set. J Cardiovasc Pharmacol 1988; 12(Suppl. 3)S121–S129
- Schork N. J., Weder A. B., Schork M. A., Bassett D. R., Julius S. Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Statistics in Medicine 1990; 9: 301–314
- Anderson E. A., Sinkey C. A., Lawton W. J., Mark A. L. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings. Hypertension 1989; 14: 177–183
- Esler M., Jennings G., Biviano B., Lambert G., Masking G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 1986; 8(Suppl. 5)S39–S43
- Mancia G., Saino A., Grassi G. Interactions between the sympathetic nervous system and the renin angiotensin system. Hypertension. Pathophysiology, Diagnosis, and Management, J. H. Laragh, B. M. Brenner. Raven Press, New York 1995; 399–407
- Palatini P., Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 1–15
- Palatini P., Casiglia E., Pauletto P., Staessen J., Kaciroti N., Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities. A study with mixture analysis in three populations. Hypertension 1997; 30: 1267–1273
- Lown B., Verrier R. L. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165–1170
- Julius S. Sympathetic hyperactivity and coronary risk in hypertension (Corcoran Lecture). Hypertension 1993; 21: 6
- Julius S., Gudbrandsson T., Jamerson K., Shahab S. T., Andersson O. Hypothesis. The hemodynamic link between insulin resistance and hypertension. J Hypertens. 1991; 9: 983–986
- Jamerson K. A., Julius S., Gudbrandsson T., Andersson O., Brant D. O. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21(5)618–623
- Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561–1566
- Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982; 62: 347–503
- Harrap S. B., Van der Merwe W. M., Griffin S. A., Macpherson F., Lever A. F. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990; 16(6)603–614
- Australian National Blood Pressure Study. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261–1267
- Nesbitt S. D., Amerena J. V., Grant E., et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens. 1997; 10: 1270–1280